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to which gene was the SMA gene and what determined
phenotype. To determine which of these two candidateSpinal Muscular Atrophy (SMA)
genes was the SMA gene, it was important to identify
Proximal SMA is an autosomal recessive disorder that nondeletion mutations within the genes in SMA pa-
results in destruction of the motor neurons in the ante- tients. During the past 2 years, a series of missense and
rior horn of the spinal cord. SMA has an estimated frameshift mutations in the SMNT gene has been identi-
incidence of 1/10,000 live births, with a carrier fre- ﬁed in patients with SMA who have an intact NAIP5
quency of 1/40 (Pearn 1980). The childhood SMAs can gene (table 1). This strongly indicates that the SMNT
be classiﬁed into three groups based on age at onset and gene is the causative SMA gene.
clinical course. Type I SMA is the most severe form, Since 95% of SMA patients have no detectable
with onset of symptoms before the age of 6 mo and with SMNT, regardless of clinical phenotype the genotypic
death occurring within the ﬁrst 2 years of life. Type II difference between a type I SMA patient with no SMNT
SMA patients have an intermediate severity, with onset and a type II or type III SMA patient with no SMNT
before age 18 mo and with patients never gaining the has required clariﬁcation. Previous studies suggested
ability to walk. Type III SMA is the mildest form of this that the loss of the SMNT gene occurs by two different
disease, with onset after the age of 18 mo and with mechanisms: deletion or conversion of SMNT to
patients achieving the ability to walk. SMNC, in which case conversion could produce a mild-
All three forms of SMA have been mapped to 5q12- SMA allele and deletion could produce a severe-SMA
13 (Brzustowicz et al. 1990; Melki et al. 1990; Simard allele. However, physical evidence for conversion was
et al. 1992; Francis et al. 1993; Brahe et al. 1994; Bur- lacking. In this issue of the Journal, Campbell et al.
ghes et al. 1994a; Wirth et al. 1994, 1995a). In 1995, (1997) present physical evidence for conversion of
three papers reported different cDNAs (neuronal SMNT to SMNC on mild-SMA chromosomes, which,
apoptosis inhibitory protein [NAIP] [Roy et al. 1995], when combined with data from assays that measure
survival motor neuron [SMN] [Lefebvre et al. 1995], SMNC and SMNT gene copy number, does provide a
and XS2G3 [XS2G3 is a segment of the NAIP gene] much needed vision of the molecular basis of genotype/
[Thompson et al. 1995]) that detect deletions in SMA phenotype relationship in SMA.
patients. The NAIP and SMN genes are duplicated with
a telomeric SMN (SMNT) and a centromeric SMN The SMA Duplicated Region and the Genes That It
(SMNC), and NAIP is duplicated either with exon 5 Contains
(NAIP5) or without exon 5 (NAIPD). The NAIP5 gene
Markers and genes that lie within the SMA region arewas deleted in 50% of type I SMA patients, whereas the
represented multiple times on a chromosome and vary intelomeric SMNT gene was deleted in 95% of patients of
copy number in different individuals (Kleyn et al. 1993;all severities (Cobben et al. 1995; Hahnen et al. 1995;
Burghes et al. 1994b; DiDonato et al. 1994; Melki et al.Lefebvre et al. 1995; Rodrigues et al. 1995; Matthijs et
1994; Lefebvre et al. 1995; Roy et al. 1995; Thompson etal. 1996; Velasco et al. 1996; DiDonato et al. 1997).
al. 1995). Physical maps of the region have been con-These reports gave optimism that the molecular nature
structed, but there is no consensus map, because of theof SMA could be clariﬁed but resulted in confusion as
instability of the YACs, the repeated nature of the region,
and its variation on different chromosomes (Francis et al.
1993; Kleyn et al. 1993; Carpten et al. 1994; Melki et al.
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Table 1 Table 2
Small Mutations of SMNT Distribution of SMNc Copy Number
NO. (%) OF INDIVIDUALSSMA
Mutation Type(s) Source FOR SMNc COPY NUMBER
GROUP (NO. OF
INDIVIDUALS) 0 1 2 3 44-bp deletion exon 3a I–III Bussaglia et al. (1995)
5-bp deletion exon 3 I Brahe et al. (1996)
11-bp duplication in exon 6b I Parsons et al. (1996) Normal (53) 4 (7.5) 25 (47.2) 23 (43.4) 1 (1.9) 0
Type I SMACodon 279 GrV I Talbot et al. (1997)
Codon 272 YrC Ic Lefebvre et al. (1995), (21) 0 8 (38.1) 9 (42.9) 4 (19.0) 0
Type II and typeRochette et al. (in press)
Codon 245 PrL III Rochette et al (in press) III SMA (58) 0 7 (12.0) 28 (48.3) 20 (34.5) 3 (5.2)
Codon 274 TrI III Hahnen et al. (1997)
Codon 262 SrI III Hahnen et al. (1997),
McAndrew et al. (1997)
Codon 275 GrS III Burglen et al. (1996b ) SMA locus, rather than being an epigenetic effect. First,
the NAIP5 gene is deleted in Ç50% of type I SMA pa-
a Found in the Spanish population; the type II case was consanguine- tients but is much less frequently deleted in type II and
ous.
type III SMA patients (Cobben et al. 1995; Hahnen etb Has now been found in two additional unrelated patients with
al. 1995; Roy et al. 1995; Thompson et al. 1995; Ro-type I SMA (D.W. Parsons and T.W. Prior, personal communication).
c Phenotype reported for one patient (Rochette et al., in press). drigues et al. 1996; Velasco et al. 1996). Second, the
polymorphic markers adjacent to SMNT and SMNC can
be used as an indicator of the copy number of these
van der Steege et al. 1995). The NAIP gene is present
genes. These marker studies demonstrate an association
in multiple copies, but the copy that is associated with
of SMNC copy number with phenotype, in the following
deletions in SMA patients can be distinguished because
manner. Approximately 50% of type I SMA patients
only this copy contains exon 5 (referred to here as
have a single copy of SMNC on each chromosome, so
‘‘NAIP5’’) (Roy et al. 1995). Another gene in the region,
that the SMNT gene is deleted and SMNC copy number
BTF2p44, also exists as multiple copies, but only one
is unaffected (DiDonato et al. 1994; Melki et al. 1994;
copy, BTF2p44T, is associated with SMA deletions (Bu¨r-
Lefebvre et al. 1995; Wirth et al. 1995b). The genotype
glen et al. 1997; Carter et al. 1997). The SMA locus
(1,1) of one copy of SMNC on each chromosome, to-
and the position of these genes, as well as polymorphic
gether with the loss of NAIP5, occurs only on type I
markers associated with the SMNT and SMNC gene, are
SMA chromosomes and implies a large deletion. (Wirth
diagrammed in ﬁgure 1 and listed in table 2. Because
et al. 1995b; Burlet et al. 1996; Rodrigues et al. 1996;
these markers are highly informative, they can be used
Simard et al., in press). In type II and type III SMA,
to determine the copy number of the combined SMNT
although they lack SMNT, they most often have one
and SMNC genes on chromosomes.
chromosome with one copy of SMNC and have the other
Evidence for Conversion and Deletion of SMNT in chromosome with two copies of SMNC (DiDonato et
SMA al. 1994; Wirth et al. 1995b). In type II and type III
SMA, the SMNT gene is missing, but the NAIP5 gene isA number of observations indicate that the variation
present, as are the markers that lie in the 5 end of thein phenotypic severity results from alterations at the
SMNT gene. Because the SMNT gene is not detected but
the markers reveal that the locus is still present, another
mechanism besides deletion of SMNT must be operating;
the most likely mechanism is conversion of SMNT
to SMNC.
Further insight into the role of SMNC-gene copy num-
ber was gained by the use of carrier parent DNA samples
and scanning densitometry to measure SMNT:SMNC ra-
tios. Analysis of SMNC copy number by use of the
SMNT:SMNC ratio in obligate carriers of type I, type II,
or type III SMA indicated that type II and type III SMA
Figure 1 Diagrammatic representation of the SMNT locus, carriers have more copies of SMNC than do type I SMA
showing positions of markers and genes. The SMNC locus is similar carriers (Velasco et al. 1996). Because the SMNT gene
but lacks the NAIP gene containing exon 5. It is most likely that the
is absent in all SMA types, the increase in SMNC copytelomeric locus and centromeric locus can exist in either orientation,
number indicates that a large number of type II and typedepending on the particular chromosome. The marker Ag1-CA (C272)
lies at the 5 end of the SMN genes (Bu¨rglen et al. 1996a). III SMA chromosomes contain a converted allele, rather
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than a deleted allele. The critical element in these studies
is an assay that measures the number of copies of SMNC
independently of the SMNT gene, because the number
of SMNC and SMNT genes varies in different chromo-
somes. Such an assay is also useful for detection of non-
deletion patients and carriers. In the June and July issues
of the Journal, two independent papers report methods
for determining the copy number of the SMNC and
SMNT genes. The strategies used differ: McAndrew et
al. (1997) used multiplex PCR and compared the copy
number of SMNT and SMNC to that of an exon of the
CFTR gene, whereas Campbell et al. (1997) used pulsed-
ﬁeld gel electrophoresis to assay the number of SMNT
and SMNC genes. The NAIP5 gene lies 3 of the SMNT Figure 2 Distribution of SMNC in the SMA-carrier population
and in the normal population. The two-copy SMNC chromosomes aregene (see ﬁg. 1), and the two are in a single EagI or
associated with the SMA chromosomes.BssHII fragment. Using probes speciﬁc for the NAIP5
gene and probes that detect both of the SMN genes,
Campbell et al. (1997) demonstrate that there is a re-
markable variability in the size of the fragments con- distribution of copies in the population should shift by
one copy number along the x-axis, and one would pre-taining the SMNC gene or the SMNT gene. In most cases
the copy number of the SMNC gene is obtained by count- dict a corresponding decrease in the number of individu-
als with only a single copy of SMNC. Indeed, this is theing the number of bands that are detected with the SMN
probes but not with the NAIP5 gene probe, and the case, as can be seen in ﬁgure 2, which shows 25/53
normals having a single copy of SMNC and only 7/58number of SMNT genes is determined by counting the
number of bands that are detected with both NAIP5 and type II and type III SMA carriers having a single copy of
SMNC. This is consistent with a mild-SMA chromosomeSMN. The fragment-size variability between individuals
explains some of the difﬁculty in assembling physical containing a conversion event. Correlation of SMNC
copy number with marker data will allow a more com-maps of this region. As expected, in normal individuals
there are usually two copies of SMNC and two copies plete analysis of the frequency and extent of deletion
and conversion events that occur in the different SMAof SMNT, indicating that there is one copy of each gene
on a chromosome. types.
Chimeric genes have been identiﬁed as SMA allelesThe importance of an assay that measures the SMNC
and SMNT copy number is that it can distinguish be- (Lefebvre et al. 1995; Devriendt et al. 1996; Hahnen et
al. 1996; van der Steege et al. 1996; DiDonato et al.tween the loss of SMNT by deletion and the loss of
SMNT by conversion. In conversion of SMNT to SMNC, 1997) and can arise by one of two mechanisms: (1) a
deletion that removes the material between the SMNTthere is gain of a copy of SMNC, which will alter the
distribution of SMNC alleles; deletion of SMNT will not and SMNC gene and fuses the 5 end of the SMNC gene
to the 3 end of the SMNT gene or (2) a conversion eventalter the distribution of SMNC alleles. Indeed, if conver-
sion is a common mechanism in the generation of mild- that effects exon 7, but not exon 8, of the SMNT gene
(Hahnen et al. 1996). The chimeric genes formed bySMA alleles, we would expect the whole distribution to
shift one copy number along the x-axis (see ﬁg. 2) as deletion and joining of SMNC to SMNT are severe-SMA
alleles. Hahnen et al. (1996) showed that chimeric SMNeach allele group gains an SMNC allele. Examination of
the data in the report by McAndrew et al. (1997), for genes can occur in type I SMA chromosomes such that
there is one chimeric gene and one SMNC gene on athe SMA carriers of the different phenotypic classes,
clearly shows this shift in the distribution. In normal chromosome (evidence is based on marker studies).
Given that there are chromosomes in the normal popula-individuals, 1/53 had three copies of SMNC, 4/21 type
I SMA carriers had three copies of SMNC, and 20/58 tion that have two copies of SMNC and one copy of
SMNT, the chimeric gene in these SMA individuals couldtype II and type III SMA carriers had three copies of
SMNC. The chromosomes with two copies of SMNC have arisen by either a deletion event or a conversion
event. If conversion can give rise to a severe-SMA allelewere associated with the SMA chromosome in these car-
rier individuals (P. E. McAndrew, personal communica- (note that three copies of SMNC does occur slightly more
frequently in type I SMA than in the normal population),tion). This indicates that chromosomes with more than
one copy of SMNC are more common in type II and then the extent of conversion might be different in se-
vere-SMA and mild-SMA alleles. Interestingly, Bussagliatype III SMA, which is consistent with gene conversion
giving rise to mild-SMA alleles. If gene conversion is et al. (1995) reported a mild-SMA patient who had a
conversion event conﬁned to exon 7, which would indi-a common event in mild-SMA chromosomes, then the
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cate that the change in exon 7 critically affects SMN SMA patients who have one, two, or three copies of
SMNC and then to study representative members of eachalthough it does not alter the encoded amino acids.
Although the studies described above indicate that group, by use of the pulsed-ﬁeld gel electrophoresis
assay. There are a number of reports of families in whichgene conversion is the likely mechanism in SMA, it is
the experiments of Campbell et al. (1997) that provide two sibs have remarkably discordant phenotypes
(Muller et al. 1992; Burghes et al. 1994a; Cobben et al.the physical evidence that conversion, and not deletion,
has occurred in mild-SMA chromosomes. They analyzed 1995; Hahnen et al. 1995; Wang et al. 1996; DiDonato
et al. 1997), with one individual being asymptomaticDNA from type I SMA patients who lack the NAIP5
gene and from type II and type III SMA patients who and the other being an SMA phenotype but with both
of them lacking the SMNT gene. It is most likely thathave the NAIP5 gene. None has a detectable SMNT gene.
In the type I SMA patients, it is not surprising that there conversion—and not deletion—has occurred in these
patients, but the copy number of SMNC does not explainwere (a) no fragments detectable with the NAIP5 probes
and (b) not a change in the number of SMNC copies the phenotypic variation (McAndrew et al. 1997). It
is now clear that absence of SMNT is caused by bothcompared with that in the normal individuals, indicating
that a deletion that removed SMNT had occurred in conversion events and deletion events, with the conver-
sion events predominating on mild-SMA chromosomesthese cases. In the type II and type III SMA cases which
had the NAIP5 gene, a single band cohybridized with the and with deletion predominating on severe-SMA chro-
mosomes.SMN and NAIP5 probes. Since the NAIP5-gene probes
detects the telomeric locus, this indicated that these
mild-SMA individuals have one copy of the SMNT locus Models of SMA and What SMNC Alleles Do
but that at least exons 7 and 8 of this SMNT gene contain
the sequences usually associated with the SMNC gene. It is now clear that loss of the SMNT alleles on both
chromosomes is the ﬁrst determinant of the SMA pheno-This demonstrated that one chromosome of the mild-
SMA individual contained a conversion event, rather type but that the mechanism of loss, deletion, or conver-
sion is important in the determination of phenotypicthan a deletion event, providing physical evidence of a
conversion event. severity. We have previously suggested a model for SMA
in which type I SMA patients contain two severe-SMAAs Campbell et al. indicate, one interesting group of
patients to study with this assay would be type I SMA alleles, type II SMA patients contain a mild-SMA allele
and a severe-SMA allele, and type III SMA patients con-patients with a detectable NAIP5 gene. Would these pa-
tients show a deletion of SMNT so that there were no tain two mild-SMA alleles (DiDonato et al. 1994, 1997;
Wirth et al. 1995b). It has now become clear that con-NAIP exon 5–SMN cohybridizing bands, or would
some of the alleles in type I SMA patients be conversion version predominates on mild-SMA chromosomes and
that deletions predominate on severe-SMA chromo-alleles? Speciﬁcally, do type I SMA patients who have
three copies of SMNC or patients with chimeric genes somes. But what modiﬁes the phenotypic severity of
SMA? Analysis of the copy number of the SMNC andassociated with two copies of SMNC conversions or de-
letions? If conversion does occur in type I SMA, then is SMNT genes demonstrates that in the different SMNC-
copy-number classes there are SMA patients of all clini-it the extent of conversion 5 of exon 7 that distinguishes
the mild-SMA SMNC alleles from the severe-SMA cal types. Thus a type I SMA patient can have two copies
of SMNC, and so can a type II or type III SMA patient.SMNC alleles? If this is the case, what are the critical
elements 5 of exon 7 that are altered in severe-SMA This indicates that the copy number of SMN does not
directly inﬂuence the phenotype. However, what can beconversions? One difﬁculty that should be kept in mind
is the possibility that on some chromosomes the orienta- said on the basis of the present data is that there are
two types of SMNC alleles—(1) one that is generatedtion of the gene clusters is ﬂipped so that the NAIP5
gene does not lie between the SMNC and SMNT genes by conversion and that lies close to the NAIP5 and (2)
the normal SMNC gene. Indeed, analysis of copy numberand the SMNC and SMNT lie adjacent to each other. In
the case of a deletion occurring on such a chromosome, of SMNC, combined with protein analysis, indicates that
not all SMNC alleles are equivalent and that those in typeit is possible that the NAIP5 gene gets placed adjacent
to the SMNC gene, but then the allele would not have II and type III SMA patients are capable of producing
proteins that form gems (punctate nuclear structuresarisen by conversion.
In the case of mild-SMA conversion events, do type containing SMN protein [Liu and Dreyfuss 1996])
whereas those in type I SMA patients are not (CoovertII and type III SMA patients who have a single copy of
SMNC have a conversion allele? Although this is most et al., in press). What is the molecular difference between
an SMNC gene that can partially complement the losslikely the case, further studies will be necessary to delin-
eate these events. In particular, it will be very useful to of SMNT and an SMNC gene that cannot complement
the loss of SMNT? There are two possibilities that comeuse the SMN dosage analysis, in combination with
marker analysis, to identify type I, type II, and type III to mind: (a) position effect and (b) other sequence
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Figure 3 Model of alleles present in the normal population and in the SMA population. A combination of two severe-SMA alleles results
in type I SMA; a combination that results in one copy of SMNT/C or SMNT/C/T results in type II SMA; and a combination that results in two
copies of the SMNT/C or SMNT/C/T results in type III SMA. SMNT/C are alleles that retain the 5 end of SMNT but not the 3 end (exons 7 and
8 contain the base changes associated with SMNC); SMNT/C/T is a rare conversion allele, in which exon 7 of SMNT is converted to SMNT);
and SMNex8T/C is an allele in the normal population and contains the SMNC exon 8 but the rest of the gene is SMNT. The chromosome
containing two copies of the modifying SMNT/C should always give rise to a mild-SMA phenotype. The exact difference between SMNT/Cs that
allows it to modify the phenotype, whereas SMNC cannot, is unknown at present.
changes between the SMN gene that affect either expres- type III SMA. A converted allele would, in most in-
stances, be equivalent to the modifying SMN allele. Asion or the type of SMN protein produced. The complete
genomic sequence of the SMNC and SMNT genes is near- model of the normal and SMA alleles is shown in ﬁgure
3. This model in some ways recalls the original sugges-ing completion, and comparison of these sequences
clearly shows that there are only minor changes between tions of Becker (1964), who suggested the possibility of
a modifying gene.SMNC and SMNT genes, with some of these minor
changes probably representing polymorphic variants (J. In conclusion, these are exciting times in SMA research.
The gene has been cloned, various mutations have beenMcPherson, personal communication). The availability
of the genomic sequence should allow differentiation of identiﬁed, and the distinction between conversion events
and deletion events has revealed a correlation of pheno-these two possibilities.
In the future the study of SMN knockout mice and type with genotype. Further work is required to clearly
deﬁne the mechanism by which the converted alleles mod-transgenes that express the human SMNC and SMNT
genes separately should determine the contribution of ify phenotype, and it is possible that deletion of adjacent
genes, such as NAIP, could inﬂuence the exact severity ofthe SMNC gene to severity of the SMA phenotype. The
models that have been presented elsewhere (Wirth et al. the phenotype. However, it appears most likely that the
deletion of NAIP marks the extent of the deletion and that1995b; Campbell et al. 1997; Didonato et al. 1997) can
now be elaborated to account for the possibility of two different forms of SMNC modify the SMA phenotype. This
is not to say that NAIP cannot protect motor neuronsdifferent types of SMNC genes (ﬁg. 3). One type of
SMNC gene (SMNT/C and SMNT/C/T, which are created from cell death and that it can be explored as a target for
therapeutic intervention, but perhaps the most intriguingby a conversion that does not extend through the 5 end
of the SMNT) is capable of modifying the phenotype, target is the SMNC gene. Can the SMNC gene be activated
to compensate for SMA, as suggested by Campbell et al.whereas the other (SMNC or a conversion extending
through the entire SMNT gene) is not. Thus zero copies (1997)? Can the SMNC gene be activated to make different
forms of SMN?And what differences exist between SMNCof the modifying SMNC gene results in type I SMA, one
copy results in type II SMA, and two copies results in genes?
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Bu¨rglen L, Patel S, Dubowitz V, Melki J, Muntomi F (1996b)The SMN protein is located in nuclear structures
A novel point mutation is in the SMN gene in a patientcalled ‘‘gems’’ and is thought to have a role in RNA
with type III spinal muscular atrophy. First Congress of theprocessing (Liu and Dreyfuss 1996), but its function(s)
World Muscle Society. Elsevier, London, abstract S39is yet to be deﬁned. In SMA research there are now
Bu¨rglen L, Seroz T, Miniou P, Lefebvre S, Burlet P, Munnichmany avenues to follow: unraveling of the function of
A, Viegas E, et al (1997) The gene encoding p44, a subunit
the SMN protein, determination of the feasibility of of the transcription factor TF11H, is involved in large-scale
therapeutic approaches that activate SMNC or replace deletions associated with Werdnig-Hoffmann disease. Am J
SMNT, and studies of the genetics of this complex locus. Hum Genet 60:72–79
Research in SMA has often felt like a religious experi- Burlet P, Bu¨rglen L, Clermont O, Lefebvre S, Viollet L, Mun-
ence ﬁrmly based in the Old Testament, with pain in- nich A, Melki J (1996) Large scale deletions of the 5q13 are
speciﬁc to Werdnig-Hoffman disease. J Med Genet 33:281–ﬂicted frequently and with only glimpses of the Promised
283Land. Despite the complexities of the genomic region
Bussaglia E, Clermont O, Tizzano E, Lefebvre S, Bu¨rglen L,containing the SMA gene, the Promised Land is becom-
Cruaud C, Urtizberea JA, et al (1995) A frame-shift deletioning visible, and it is now clear that gene conversion—
in the survival motor neuron gene in Spanish spinal muscu-not religious conversion—has been one key to clarity.
lar atrophy patients. Nat Genet 11:335–337
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